GSA Capital Partners’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-131,036
| Closed | -$96K | – | 2009 |
|
|
2022
Q3 | $96K | Sell |
131,036
-1,369
| -1% | -$1K | 0.01% | 1368 |
|
|
2022
Q2 | $151K | Sell |
132,405
-18,509
| -12% | -$21.1K | 0.02% | 1143 |
|
|
2022
Q1 | $309K | Sell |
150,914
-119,858
| -44% | -$245K | 0.04% | 871 |
|
|
2021
Q4 | $780K | Buy |
270,772
+236,984
| +701% | +$683K | 0.1% | 327 |
|
|
2021
Q3 | $143K | Buy |
+33,788
| New | +$143K | 0.01% | 1290 |
|
|
2020
Q1 | – | Sell |
-22,106
| Closed | -$134K | – | 1676 |
|
|
2019
Q4 | $134K | Buy |
+22,106
| New | +$134K | 0.02% | 1317 |
|
|
2018
Q4 | – | Sell |
-21,700
| Closed | -$177K | – | 1843 |
|
|
2018
Q3 | $177K | Buy |
+21,700
| New | +$177K | 0.01% | 1509 |
|
|
2018
Q1 | – | Sell |
-38,800
| Closed | -$486K | – | 1883 |
|
|
2017
Q4 | $486K | Buy |
+38,800
| New | +$486K | 0.03% | 952 |
|
|
2017
Q3 | – | Sell |
-10,900
| Closed | -$185K | – | 1937 |
|
|
2017
Q2 | $185K | Sell |
10,900
-19,900
| -65% | -$338K | 0.01% | 1519 |
|
|
2017
Q1 | $619K | Buy |
30,800
+17,100
| +125% | +$344K | 0.03% | 965 |
|
|
2016
Q4 | $214K | Buy |
+13,700
| New | +$214K | 0.01% | 1561 |
|